- Report
- October 2025
- 81 Pages
From €3095EUR$3,450USD£2,646GBP
- Report
- June 2025
- 95 Pages
Asia Pacific
From €3543EUR$3,950USD£3,029GBP
- Report
- June 2025
- 105 Pages
Global
From €3095EUR$3,450USD£2,646GBP
- Report
- June 2025
- 80 Pages
Africa, Middle East
From €3095EUR$3,450USD£2,646GBP
- Report
- May 2025
- 188 Pages
Global
From €3241EUR$3,613USD£2,770GBP
€3812EUR$4,250USD£3,259GBP
- Report
- July 2024
- 146 Pages
Global
From €4037EUR$4,500USD£3,451GBP
- Report
- February 2026
- 95 Pages
Global
From €3500EUR$4,180USD£3,097GBP
- Report
- April 2024
- 111 Pages
Global
From €3500EUR$4,180USD£3,097GBP
- Report
- November 2023
- 106 Pages
Global
From €3500EUR$4,180USD£3,097GBP
- Report
- May 2023
- 96 Pages
Global
From €3500EUR$4,180USD£3,097GBP
- Report
- November 2023
- 114 Pages
Global
From €3500EUR$4,180USD£3,097GBP
- Report
- April 2024
- 132 Pages
Global
From €852EUR$950USD£729GBP
- Book
- July 2018
- 106 Pages

The In Vitro Assay market is a segment of the biotechnology industry that focuses on the development and production of laboratory tests and instruments used to detect and measure biological molecules. These assays are used to study the function of genes, proteins, and other molecules in a variety of biological processes. In vitro assays are used to study the effects of drugs, toxins, and other compounds on cells and tissues, as well as to diagnose and monitor diseases.
In vitro assays are used in a wide range of applications, including drug discovery and development, diagnostics, and research. They are also used in the production of biopharmaceuticals, such as vaccines and monoclonal antibodies.
Some of the major companies in the In Vitro Assay market include Thermo Fisher Scientific, Merck KGaA, Agilent Technologies, Bio-Rad Laboratories, PerkinElmer, and Roche Diagnostics. Show Less Read more